CIK 0001404281
- Non-accelerated filer
- Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- 4 Open-market sale 10% owner sold 3,566 shares at $14.26 ($50,844)
- 4 Open-market sale 10% owner sold 48,472 shares at an average $14.32 ($694,194)
- 4 Open-market sale President and CEO sold 16,000 shares at an average $13.77 ($220,240)
- 4 Open-market sale Chief Operating Officer sold 9,000 shares at an average $14.01 ($126,100)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 1,120 shares at $14.27 ($15,982)
- 4 Open-market sale 10% owner sold 20,696 shares at $14.20 ($293,883)
- 4 Open-market sale 10% owner sold 27,875 shares at $14.20 ($395,825)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 4,567 shares at $13.00 ($59,371)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 2,258 shares at $11.45 ($25,854)
- 4 Open-market sale 10% owner sold 49,141 shares at $14.50 ($712,545)
- 4 Derivatives Options or other derivatives
Page 9 of 11 · 212 filings